hims wegovy - Search News

News

Novo Nordisk ends Wegovy sales on Hims & Hers

CBS News on MSN · 3d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Novo Nordisk ends Hims & Hers deal over Wegovy knockoffs

Novo Nordisk cut ties with Hims & Hers, accusing the telehealth firm of promoting Wegovy copycat versions of the weight-loss drug.

The Motley Fool on MSN · 2d

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ending of its deal with Hims & Hers jeopardizes the healthcare platform's goal to lead the weight loss market.

24m

Why Is Hims & Hers Health (HIMS) Stock Soaring Today

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.1% in the afternoon session after the company's CEO ...

1h

What's Going On With Hims & Hers Health Stock Today?

Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Thursday. The stock appears to be bouncing back a bit after ...

1d

Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results